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Phencyclidine (PCP) was tested on the metathoracic tibialis muscles of Locusta migratoria. In physiological 
solution, the peak amplitude of the excitatory postsynaptic urrents (EPSCs) evoked by nerve stimulation 
was linearly related to membrane potential between -50 and -150 mV. The decay time constant of the EPSC 
(zspsc) was exponentially dependent on voltage and decreased with hyperpolarization. The membrane poten- 
tial change required to produce an e-fold change in rEPSC was 3 15 mV. PCP (5-40 PM) produced aconcentra- 
tion-dependent depression of both EPSC peak amplitude and r -, A slight nonlinearity in the current- 
voltage relationship could he discerned at high concentrations of PCP. The shortening of the decay time 
constant of EPSC (rEpsc) occurred without significant change in the voltage sensitivity observed under con- 
trol conditions. Under all experimental conditions, the decay of the EPSCs remained a single exponential 
of time. Fluctuation analysis indicated that 5pM PCP shortens the lifetime of the glutamate-activated chan- 
nels by 25.7 f 3 %. PCP (lo-80 PM) did not induce d~ensiti~tion ofthe glutamate r ceptors. These results 
suggest that PCP interacts with the open confo~ation of ion channels activated by the glutamate r ceptor. 
Phencyclidine Glutamate receptor Locust Neuromuscular t ansmission 
Excitatory postsynaptic current Channel blocker 
I. INTRODUCTION 
The general anesthetic and hallucinogenic agent 
‘Angel Dust’ [ 1 -( 1 -phenylcyclohexyl)piperidine, 
phen~y~lidine or PCP] is a drug of abuse when 
used chronically or in large doses. In addition, 
PCP has s~hizophrenomimetic and convulsant 
properties, and triggers unpredictable, violent 
behavior [ 1,2]. A large number of studies have 
been devoted to PCP, and it has been 
demonstrated that this agent is able to affect the 
release of many neurotransmitters such as 
!Lhydroxytryptamine 131, dopamine ]41, 
norepinephrine [5], and acetylcholine (ACh) [6]. 
Several studies have clearly described PCP as an 
~ticholinergic agent [7,8]. In our laboratory, we 
have demonstrate that the noncompetitive action 
* To whom correspondence should be addressed 
of PCP on the nicotinic ACh receptor-ion channel 
complex increases the affinity of the transmitter to 
its binding site thereby inducing activation and 
subsequent desensitization [6,8]. As a non- 
competitive antagonist of the ACh receptor, PCP 
was also able to produce blockade of its associated 
ion channel in closed [6,8] and open conforma- 
tions 161. In insects, where ACh serves as a sensory 
and central nervous system transmitter [9], it is 
well established that L-glutamate is a potent ex- 
citatory neuromuscular transmitter [IO]. The 
peripheral ocation of glutamate receptors in insect 
muscles enabled us to perform more quantitative 
electrophysiological investigations. Although 
isolation and eventual cloning of such a receptor 
are not yet possible, a few drugs have been found 
to act on the glutamate receptor such as chlorison- 
damine Ill], anti~holinester~es ]12], diltiazem 
1131, curare [14,15], gallamine 1151, and strep- 
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tomycin [16]. However, studies of the glutamate 
receptor suffer from the relative lack of potent an- 
tagonists. This study demonstrates the effects of 
PCP on locust neuromuscular junctions and iden- 
tifies a possible target of this agent on the 
glutamate receptor. 
2. MATERIALS AND METHODS 
Flexor and extensor metathoracic tibialis 
muscles of adult Locusta migratoria were dissected 
according to Hoyle [ 171. The physiological solu- 
tion had the following composition (mM): NaCl, 
170; KCl, 10; NaHzPOd, 4; Na2HP04, 6; CaC12, 
0.8. To decrease the muscle twitch during ex- 
citatory postsynaptic urrent (EPSC) experiments, 
muscles were pretreated with glycerol (150 mM) 
and MgClz (10 mM). All the preparations were 
pretreated with 1 PM concanavalin A for 30 min to 
minimize receptor desensitization [ 181 except in the 
case of experiments designed to study receptor 
desensitization. 
The voltage clamp circuit was similar to that in 
[19] with some modifications [20]. Recording and 
A B C 
-50 mV 
-70 mV 
-90 mV 
-110 mV 
-130 mV 
-150 mV 
current-passing microelectrodes were filled with 
3 M KC1 and had resistances of 3-5 W. EPSCs 
were evoked by stimulating the crural nerve 
(nerve-5), and EPSC waveforms were digitized at 
3.3 kHz by a PDP 11/40 computer. The decay 
phase (20-80%) of the EPSC was fitted by a single 
exponential function (linear regression on the 
logarithms of the data points) from which the 
EPSC decay time constant was determined. EPSC 
fluctuations induced by bath application of 
monosodium L-glutamate (50 PM) and miniature 
EPSCs (MEPSCs) were recorded on magnetic tape 
by a Racal Store 4D FM tape recorder for later 
computer analysis. Power density spectra from L- 
glutamate-induced EPSC fluctuations were ob- 
tained from high-gain AC signals after filtering 
with a Krohn-Hite 3700 bandpass filter (l-800 
Hz). Data were sampled at 2 kHz, and spectra 
were obtained by subtraction of the averaged 
baseline spectra from those during application of 
L-glutamate. The resulting power spectra were fit- 
ted to a single Lorentzian function using a 
nonlinear regression program. MEPSCs were cap- 
tured by a digital oscilloscope (Gould OS4000) 
before being sent to the computer for analysis. 
D E 
Fig.1. Effects of PCP on EPSCs. Series of EPSCs were recorded from locust flexor metathoracic tibialis muscle, at 
different membrane potentials, under control conditions (A), in the presence of 5 (B), 10 (C) and 40 (D) PM PCP, and 
after 60 min wash (E). 
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3. RESULTS In addition, PCP did not show a time-dependent 
3.1. Effects of PCF on &e peak ~~~[~t~de and 
rise time of ~g~~~~~ked excit&wy pst- 
symqvtic lm-erlts 
EPSCs were recorded from surface fibers of 
glycerol-treated locust flexor metathoracic tibialis 
muscles under control conditions and in the 
presence of PCP (fig. 1). In physiological solution, 
the peak amplitude was linearly related to mem- 
brane potential between f 50 and - 140 mV 
(fig2). Superfusion of PCP (5-40 FM) for 30 min 
produced a concentration-dependent depression of 
the peak amplitude of the EPSC. The dependence 
of the EPSC amplitude on voltage showed a slight 
nonlinearity at hy~~l~izcd potehtials, Indeed, 
at 4OpM PCP, a small upward curvature in the 
current-voltage relationship could be discerned 
(fig.2). These effects of PCP were reversed after 
washing the preparation for 60 min, the EPSC 
amplitude and the characteristics of the I/Y rela- 
tionship being recovered to those observed under 
comrol conditions. 
Fig.2. Current-voltage r lationship of EPSCs recorded 
under control conditions (O), in the presence of 5 (A), 
10 (a), 20 (e), and 40 (A) FM PCP and after 60 min 
wash Cm). Each point represents the mean f SE of 9-21 
records from 5-11 different fibers. 
effect on the EPSC amplitude in glutamate recep- 
tors, i-e., there was no ‘hysteresis loop’ in the I/V 
relationship (fig.2). Further, there was no desen- 
sitizing effect on ~ut~atergic transmission in the 
presence of PCP (IO-80 pM), since stimulation of 
the crural nerve at frequencies of lo-100 Hz did 
not cause any significant decrement in peak EPSC 
amplitude during the train of evoked currents 
(fig.3). These findings indicate some dissimilarities 
between the effects of PCP on the glutamate- 
mediated neuromuscular transmission and those 
observed on the nicotinic synapses. As reported in 
151, on the end-plate currents elicited on the frog 
neuromusc~l~ junction, PCP produces a marked 
voltage- and time-dependent depression of the 
peak amplitude with a clear upward curvature at 
hyperpolarized potentials and hysteresis loop in 
the Z/V relationship. 
The alterations of the EPSC induced by PCP 
also involved a shortening of the rise time, at con- 
centrations 2 lO/rM. For example, the EPSCs 
recorded at - 80 mV after 30 min exposure to 
PCP (20~M) showed a rise time shortened from 
2.0 * 0.09 (n = 18) to 1.5 f 0.08 ms (n = 12). 
3.2, TYre action of PCP on decey ef dze EPSCs 
In physiological solution, 7~psc was exponen- 
tially dependent on voltage and decreased with 
hyperpolarization. An e-fold change in ~psc was 
produced by about 315 mV change in membrane 
potential. The effect of PCP (5-50pM) on the 
decay of EPSCs recorded at the postjunctional 
region of the glutamatergic synapse was analyzed, 
and the concentration-dependent effect on ~“EPSC at 
membrane potentials varying from -50 to 
- 150 mV is illustrated in figd. At all the concen- 
trations of PCP tested, the decay of the EPSCs re- 
mained a single exponential function of time 
(fig.4). According to the scheme presented in sec- 
tion 4, the adequate fit of EPSC decay to a single 
exponential function of time indicates that drug 
dissociation governed by the rate constant k- 3 was 
too slow to contribute to the EPSC. Therefore, in 
the presence of PCP, the observed rate constant of 
the EPSC decay (1/7-m~) is the sum of two rate 
constants, k-2 for EPSC decay in the absence of 
drug and k3 for PCP binding, and is linearly 
related to PCP concentration, according to the 
following expression: I/~PSC = k-2 + [D]k3. Fig.5 
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Fig.% Effect of repetitive stimulation of the crural nerve on the peak amplitude of excitatory postsynaptic potentials 
recorded from flexor muscle of locust under control conditions and in the presence of 40/tM PCP. The membrane 
potential was - 30 * 2 mV. 
Llfustrates the Iinearity of the r~~~~i~n~~i~ between 
the reciprocal of rrp.5~ and FCP concentrations. 
Additionally, the similar voltage dependence of 
~=EPSC observed in the absence and in the presence 
of alf concentrations of PCP tested, suggested that 
voltage has little effect on the rate constant, k3, of 
PCP binding. All these effects of PCP were rever- 
sible since 60 min washing resulted in recovery of 
the characteristics of Y-EPSC seen under control 
conditions. 
3.3. Effect of PCP on the peak amplitude and 
decay time cmstmt of the miniature 
excltattrry ~~~t~y~~pt~~ currents (MEPSCsj 
Fig.6 shows typical MEPSCs recorded under 
control conditions and 30 min after exposure of 
locust muscle to 1OpM PCP. In physiolagic~ 
soIution, MEPSC peak amplitude and time eons- 
- 
Fig.4. Voltage- and concentration-dependent effect of 
PCP on the decay time constant of the EPSC. EPSCs 
were recorded under control conditions (o), in the 
presence of 5 (A), 10 (cI), 20 (m), and 40 (4) &I PCP 
and after 60 mm wash (D). Each plotted point represents 
the mean f SE of 9-21 records from 5-11 different 
fibers. 
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Fig.5. Relationship between the reciprocal of EPSC 
decay time constant and PCP concentration. The 
membrane potential was - 50 mV. 
tant of decay (7MEPSC) were voltage sensitive in a 
manner similar to that of EPSCs. The analysis of 
MEPSCs recorded (from the same fiber clamped at 
- 50 mV) under control conditions (n = 47) and 
after 30 min exposure to 10,~M PCP (n = 43) 
showed a decrease in peak amplitude from 11.3 f 
Iti”’ 
1 10 100 1000 
Ffequenc~~ 
Fig.6. Typical MEPSCs recorded from extensor muscle 
of locust under control conditions and in the presence of 
10pM PCP. All the MEPSCs were recorded from the 
same fiber clamped at -45 mV. 
2.0 to 6.9 rfi 1.3 nA and a shortening of TMEPSC 
from 2.2 +: 0.7 to 0.9 +- 0.5 ms. 
3.4. The action of PCP on glutamate-induced 
EPSC fluctuations 
The effect of PCP (5 ,uM) on single channel 
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Fig.7. Effect of PCP on glutamate-induced EPSC fluctuations in locust muscle. Power density spectra were produced 
by bath application of 50tM monosodium L-glutamate before (A) and after 30 min superfusion of 5 pM PCP (B). 
Spectral analysis provided a rr of 4.13 ms under control conditions, and 3.03 ms in the presence of 5 pM PCP. These 
spectra were obtained from a same fiber clamped at - 50 mV. 
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lifetime was determined from fluctuation analysis 
on voltage-clamped surface fibers of the extensor 
metathoracic tibialis muscles of the locust. 
Previous studies have shown that the channel 
lifetime of the glutamate receptor is dependent 
upon the glutamate concentrations [21]. Under 
such conditions, we used a single concentration of 
glutamate applied to the bath to generate control 
values for channel lifetime and subsequently ex- 
posed the preparation to a combination of 
glutamate and PCP (5 ,uM). Power density spectra 
obtained from the same fiber clamped at - 50 mV 
showed that PCP decreased the channel lifetime 
from 4.1 ms in control condition to 3.0 ms (fig.7). 
All the experiments were done at room 
temperature. 
4. DISCUSSION 
Several electrophysiological and biochemical 
studies have demonstrated the interaction of PCP 
with the ionic channels associated with nicotinic 
receptors at the neuromuscular junction and 
in Torpedo or Electrophorus electric organ 
[6,8]. Thus, PCP and perhydrohistrionicotoxin 
(Hrt-HTX) in their tritiated forms have been used 
extensively as important tools for identification of 
mechanisms underlying noncompetitive an- 
tagonisms at the nicotinic synapses and the active 
sites on the ionic channel [22]. The present study 
reveals that PCP blocks the glutamate-mediated 
neuromuscular transmission of the locusts. PCP at 
concentrations similar to those which block the 
neuromuscular transmission of the nicotinic 
synapses produces a depression of the peak 
amplitude and marked shortening of the decay 
time constants of EPSC and MEPSC recorded at 
the junctional region of the locust glutamatergic 
synapse. As revealed by the analysis of the 
glutamate-induced EPSC fluctuations, PCP 
decreased channel lifetime and did not change 
channel conductance. These findings suggest hat 
the hallucinogenic PCP can block the glutamate 
receptor by interfering with mechanisms involved 
in the control of ionic permeability leading to an 
action which resembles that of an ionic channel 
blocker. Therefore, most of the effects of PCP on 
the glutamate receptor appear to fit the sequential 
model [23] for open channel blockade, with a 
kinetic process similar to that used for the nicotinic 
receptor [22,24]: 
nGlu + R, + Glu,R, += 
1 2 
Glu,,R, 
D k 
3, Glu,RbD 
D k-3 
where nGlu represents n agonist (glutamate) 
molecules, R, is the resting state of the glutamergic 
channel complex, GlunRc is the agonist-bound 
(closed) state, and Glu,R, the state of the channel 
in open conformation. Glu,Rt,D is the noncon- 
ducting state in the presence of the drug D. The 
rate constants are as indicated. 
The following experimental observations are 
consistent with this model: a shortening of the 
mean channel open time with no change of the 
conductance of the elementary events (fig.7); an 
acceleration of the EPSC decays (figs 1 and 4), 
since ir~psc is a reflection of the lifetime of the 
open ion channels; a single exponential decay 
which suggested that the rate constant for PCP un- 
binding (k-3) is negligible; and linear plots of 
~/TEPSC vs PCP concentration (fig.5) with slope k3 
and intercept k-2. A comparison, however, with its 
actions on the postsynaptic nicotinic receptor-ion 
channel complex [6] shows that PCP produces a 
marked voltage-dependent acceleration of the 
decay of endplate currents due to an opposing 
voltage dependence of these two rate constants, 
k-2 and k3. The fact that the voltage sensitivity of 
jr~psc, observed under control conditions, remain- 
ed unchanged in the presence of PCP suggested lit- 
tle influence of voltage on k3, thus suggesting a 
very external location of PCP binding site on the 
postsynaptic glutamate receptor at the locust 
neuromuscular junction. 
The present results suggested that in contrast to 
PCP’s actions on the ACh-mediated nicotinic 
synapses where this agent interacts with both open 
and closed conformations of the nicotinic recep- 
tor, on the glutamate receptor this agent acts as a 
noncompetitive antagonist, primarily blocking the 
open ionic channels. Therefore PCP may be a 
useful tool for the biochemical characterization 
and possible isolation of the glutamate receptor of 
the locust. If, to some extent, the glutamate recep- 
155 
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tori involved in the neuromuscular transmission of 
the locust are similar to those located in central 
nervous system of different species (e.g. vertebrate 
brain), one could assume the implication of 
glutamergic synapses in the clinical actions and 
symptomatology induced by PCP. 
In summary, our studies show a noncompetitive 
blockade of the glutamate receptor produced by 
PCP through an interaction with the open confor- 
mation of the ion channels activated by this recep- 
tor. In these synapses PCP apparently does not in- 
teract with the receptor recognition sites. Thus, 
these findings provide evidence of PCP actions at 
the glutamate-mediated neuromuscular junction of 
the locust and reveal some similarities between the 
ion channels of the nicotinic and glutamergic 
synapses. 
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